Secarna Pharmaceuticals and Curie.Bio portfolio company enter research and option agreement
May 14, 2025Research and Development Corporate, Cure.Bio Portfolio Company, Pharmacy, Secarna Pharmaceuticals, agreement
Global biopharma company, Secarna Pharmaceuticals, and biotech investor, Cure.Bio, have announced signing a research and option agreement, intending to accelerate …
Tozaro forms Technical Advisory Board to accelerate Smart Polymer commercialisation for CGT bioprocessing
May 14, 2025Manufacturing and Production, Research and Development CGT production, Cell and Gene Therapy (CGT), Contraception, Pharmacy, Tozaro, advisory board
Tozaro, a UK-based biopharma focused on cell and gene therapy (CGT), has announced the formation of a Technical Advisory Board …
Hansa Biopharma appoints Maria Törnsén as chief operating officer and US president
May 14, 2025Research and Development Corporate, Hansa Biopharma, Immunology, Pharmacy, biopharma, chief operating officer (COO), immunology
Swedish biopharma company Hansa Biopharma has appointed Maria Törnsén as chief operating officer (COO) and president US effective 19 May …
Donato Spota appointed as chief financial officer at Eleva
May 14, 2025Research and Development Eleva, Pharmacy, appointment, biopharma, chief financial officer (CFO)
German biopharma company, Eleva, has appointed Donato Spota as its new chief financial officer (CFO) and managing director to support …
Newron’s programme for treatment-resistant schizophrenia therapy approved
May 13, 2025Research and Development Newron, Psychiatry, clinical trials, psychiatry, schizophrenia
Newron Pharmaceuticals has announced the approval for its ENIGMA-TRS phase 3 development programme evaluating evenamide as an add-on therapy to …
Terumo’s plasma donation system adopted by Join Parachute to expand access to lifesaving therapies
May 13, 2025Biotech/start-up, Sales and Marketing Haematology, Join Parachute, Pharmacy, Terumo Blood and Cell Technologies (Terumo BCT), biotech, plasma donation
US Biotech company, Terumo Blood and Cell Technologies (Terumo BCT), has announced that Join Parachute will adopt its Rika Plasma …
Thermosome secures FDA Orphan Drug Designation for soft tissue sarcoma therapy
May 12, 2025Research and Development European Medicines Agency (EMA), FDA, Oncology, Thermosome
Thermosome has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for its lead candidate, THE001, …
Novo Nordisk unveils new semaglutide data on obesity and heart disease at ECO 2025
May 12, 2025Research and Development Cardiology, Novo Nordisk, Obesity, Ozempic, cardiometabolic conditions, heart disease, obesity, semaglutide
Danish biopharma, Novo Nordisk, has announced that it will present new data on metabolic and cardiovascular health at the upcoming …
Moderna expands use of AI-ready R&D platform
May 12, 2025Business Services, Research and Development, Technical Consultancy AI, Benchling, Corporate, Moderna, R&D, digital transformation
Moderna has expanded its partnership with Benchling, a cloud-based research platform, to support its broader research organisation. Previously used by …
European Commission approves Johnson & Johnson’s Crohn’s disease therapy
May 12, 2025Market Access, Research and Development, Sales and Marketing Crohn’s disease, European Commission, Gastrointestinal tract, Johnson & Johnson, guselkumab, marketing authorisation
The European Commission (EC) has granted Marketing Authorisation (MA) to Johnson & Johnson’s Tremfya (guselkumab) for the treatment of moderately …
Mind the gap: men’s health and the need for progress
May 12, 2025Advocacy Development, Medical Communications, Medical Education, Research and Development Androlabs, Men's Health Strategy, Men's mental health, Movember Foundation, Pharmacy, Psychiatry, mental health
From prostate cancer to hormonal health, many areas of men’s health require more attention. As male life expectancy and healthy …
Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases
May 9, 2025Research and Development Galimedix Therapeutics, Neurology, Opthalmology, R&D, clinical trial, neurodegenerative conditions
Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study …
Apiary invests in life sciences SEO pioneer PIO to support global expansion
May 9, 2025Agency, Business Services, Marketing Consultancies AI, Apiary Capital, Corporate, PIO, SEO, agency, investment, performance marketing, performance-io
Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to …
AAX Biotech announces collaboration for cardiovascular antibody therapy
May 8, 2025Research and Development AAX Biotech, Cardiology, antibody therapies, collaboration, research and development
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of antibody-based therapies targeting cardiovascular disease. …
Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds
May 8, 2025Research and Development AI, Corporate, Devices, EU Data Act, HCPs, Johnson & Johnson, Pharmacy, digital technology, survey
A global survey by Johnson & Johnson MedTech has revealed that a majority of Europeans are willing to share their …
Bristol Myers Squibb appoints Cari Gallman as executive vice president, general counsel and chief policy officer
May 8, 2025Business Services, Legal, Research and Development Corporate, appointment, bristol myers squibb
Global biopharma company, Bristol Myers Squibb, has announced the appointment of Cari Gallman as executive vice president, general counsel and …
Digital Control Room, a major pharma provider, wins King’s Award for Enterprise
May 7, 2025Business Services, Medical Communications Digital Control Room, King's Award for Enterprise, Pharma services, Pharmacy, UK
Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online content, will receive a King’s …
ENA Respiratory appoints two strategic advisors to support leading project
May 7, 2025Research and Development Ena Respiratory, Infections and infestations, Respirology, strategic adivsors
ENA Respiratory, focused on minimising the impact of viral respiratory infections, has announced the appointment of Kenny Simmen (pictured left) …
Alchemab Therapeutics signs $415m licensing agreement for ALS programme with Eli Lilly
May 7, 2025Mergers and Acquisitions Alchemab Therapeutics, Corporate, Eli Lilly and Company, Immunology, M&A, als, immunology, neurodegenerative conditions
Alchemab Therapeutics, an immunotherapy-focused biopharma company, has entered a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, its …
Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant
May 6, 2025Mergers and Acquisitions (OTC & VMS), Clayton, Clayton Dubilier & Rice (CD&R), Corporate, M&A, Opella, Sanofi, agreement
Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofi’s …
